肾移植后红细胞增多症

目的 分析肾移植后红细胞增多症（PTE）的发生情况及易发因素。方法 就其性别、移植前血色素（Hb)／红细胞压积（Hct)、移植前后高血压、发病前血尿素氮（BUN）／肌酐（Cr)、发病前促红素（EPO）应用、免疫抑制剂应用等，与非PTE组对照。结果 50例肾移植后发生PTE9例，发病率18％，发病时间平均6.8个月。结论 PTE好发于移植前Hb/Hct相对较高、移植前后血压较高、移植后肾功能良好的男性肾移植受。

Erythrocytosis after renal transplantation

Objective To analyze the incidence and susceptible factors of erythrocytosis after renal transplantation. Methods The patients with erythrocytosis after renal transplantation were contrasted to the patients without erythrocytosis, who were studied about the sex?ferrohemoglobin/ haematocrit?hypertension of anterior and post transplantation?the ratio of blood urea nitrogen/ creatinine ?application of erythropoietin and immunosuppressive agent before episode. Results 9 of 50 cases after renal transplantation occurred the erythrocytosis, the incidence was 18%. The duration of episode average 6.8 months. Conclusion Erythrocytosis after renal transplantation tendency to the patients with the higher ratio of ferrohemoglobin/ haematocrit?hypertension of anterior and post transplantation and the male patients with good renal function after renal transplantation.